| Politician | Action | Description | Traded |
|---|---|---|---|
| Sell | Anavex Life Sciences Corp. | Dec 12, 2022 | |
| Buy | Anavex Life Sciences Corp. | Oct 12, 2022 |
This page tracks congressional stock trading activity in Anavex Life Sciences Corp. (AVXL) in the Healthcare sector. Disclosed Capitol has indexed 2 disclosed congressional trades involving AVXL. Every trade is sourced from official STOCK Act financial disclosure filings — the same primary records the Senate and House are required to publish. The full trade list with politician names, transaction types, amount ranges, and disclosure dates is below, alongside cross-references to any related lobbying activity, federal contracts, and committee assignments.
As of January 2023 — Disclosed Capitol has tracked 2 disclosed congressional trades in Anavex Life Sciences Corp. (AVXL) — 1:1 buy-heavy ratio — led by Christopher L. Jacobs (R).
| Date | Politician | Party | Action | Amount |
|---|---|---|---|---|
| Dec 12, 2022 | Christopher L. Jacobs | R | Sell | $1,001 - $15,000 |
| Oct 12, 2022 | Christopher L. Jacobs | R | Buy | $1,001 - $15,000 |
Across the 2 disclosed congressional trades in Anavex Life Sciences Corp. (AVXL), members of Congress have reported 1 buy and 1 sell. The average 30-day alpha vs. the S&P 500 is 22.76%.
As of September 2026, corporate insiders at Anavex Life Sciences Corp. have filed 0 SEC Form 4 transactions in AVXL over the past 12 months.
| Date | Insider | Action | Value |
|---|---|---|---|
| 2026-09-24 | Boenisch Sandra — PFO & Treasurer | Award | — |
| 2026-09-24 | Boenisch Sandra — PFO & Treasurer | Award | — |
Insider transactions are parsed from SEC Form 4 filings and shown alongside the congressional trades above. Institutional 13F positions are tracked separately on the institutional holdings page.
For fiscal year 2025, Anavex Life Sciences Corp. reported net income of -$47.5M, per SEC filings.
Most recent reported quarter: Q3 FY2026 — revenue —, net income $7.8M.
Figures come from SEC financial statement filings. The full annual and quarterly statement history is in the Financials tab above.